Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0X0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,276
Award facts
- Contract value 100% obligated
- $64,275.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $64,275.96 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order was issued on December 29, 2025, with an ultimate completion date of December 30, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains through competitive awards with the DLA. Ozempic, a diabetes management medication, aligns with AmerisourceBergen's established role supplying specialty and chronic disease medications to Defense Health Agency and other federal healthcare customers. The SPE2DX prime vendor contract represents a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply diverse medical commodities supporting military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FA0X0?
SPE2DR26FA0X0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FA0X0 worth?
The government has obligated $64,276 on SPE2DR26FA0X0.
Is contract SPE2DR26FA0X0 an order under another contract?
Yes. SPE2DR26FA0X0 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA0X0 competed?
The extent of competition for SPE2DR26FA0X0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award